Biblio

Export 751 results:
Author Title Type Year
Filters: First Letter Of Keyword is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Peptide Fragments
E. Chiziane, Telemann, H., Krueger, M., Adler, J., Arnhold, J., Alia, A., and Flemmig, J., Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 963-984, 2018.
M. Wei, Zhao, B., Huo, K., Deng, Y., Shang, S., Liu, J., Li, Y., Ma, L., Jiang, Y., Dang, L., Chen, C., Wei, S., Zhang, J., Yang, H., Gao, F., and Qu, Q., Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults., J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.
G. Lombardi, Berti, V., Tedde, A., Bagnoli, S., Piaceri, I., Polito, C., Lucidi, G., Ferrari, C., Ginestroni, A., Moretti, M., Pupi, A., Nacmias, B., and Sorbi, S., Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier., J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway., J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
M. Romeo, Stravalaci, M., Beeg, M., Rossi, A., Fiordaliso, F., Corbelli, A., Salmona, M., Gobbi, M., Cagnotto, A., and Diomede, L., Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity., J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
Y. Huang, Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W. - X., and Zhang, Y. - X., Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity., J Alzheimers Dis, vol. 57, no. 3, pp. 885-897, 2017.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia., J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
M. E. Flanagan, Larson, E. B., Walker, R. L., C Keene, D., Postupna, N., Cholerton, B., Sonnen, J. A., Dublin, S., Crane, P. K., and Montine, T. J., Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex., J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.
O. M. Volpina, Samokhin, A. N., Koroev, D. O., Nesterova, I. V., Volkova, T. D., Medvinskaya, N. I., Nekrasov, P. V., Tatarnikova, O. G., Kamynina, A. V., Balasanyants, S. M., Voronina, T. A., Kulikov, A. M., and Bobkova, N. V., Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice., J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40., J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
Z. Liu, Kameshima, N., Nanjo, T., Shiino, A., Kato, T., Shimizu, S., Shimizu, T., Tanaka, S., Miura, K., and Tooyama, I., Development of a High-Sensitivity Method for the Measurement of Human Nasal Aβ42, Tau, and Phosphorylated Tau., J Alzheimers Dis, vol. 62, no. 2, pp. 737-744, 2018.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., Plasma Biomarkers of Alzheimer's Disease in African Americans., J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid., J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons., J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
S. Tran, Kuruppu, S., and Rajapakse, N. W., Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?, J Alzheimers Dis, vol. 85, no. 3, pp. 943-955, 2022.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum., J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.

Pages